9 SGLT2 Inhibitors in Type 1 Diabetes (T1D) SGLT2 inhibitors may also be of beneft in T1D, in addition to insulin, although they have not yet been approved for this indication
It is not on the WADA Prohibited List, so no Therapeutic Use Exemption is required, and it is legal to use in and out of competition
The combination of vitamin C and grape-seed polyphenols increases blood pressure: a randomized, double-blind, placebo-controlled trial
Suitable delivery systems must enable the benefit of combining multiple active ingredients
doi: 10.1038/s41392-020-00349-7
These medications mimic the hormone GLP-1, which helps regulate appetite, increase feelings of fullness, and control blood sugar levels